心房颤动与痴呆:AF-SCREEN国际协作组报告
该报告由AF-SCREEN国际协作组发布,汇总房颤与认知障碍及痴呆相关联的证据,指出该关联独立于临床卒中,但直接因果性尚无定论;报告就房颤患者的痴呆评估与管理提供指导,梳理可疑病理生理机制并指出研究空白。
要点
- 房颤与认知障碍、痴呆的关联独立于临床卒中,但直接因果证据尚不充分。
- 口服抗凝在低卒中风险、短程或无症状房颤等特定亚组中的保护作用仍未知。
- 建议未来房颤研究纳入认知评估,并结合患者偏好与结局优先级。
核心结论
- 房颤与认知障碍及痴呆存在独立于临床卒中的一致关联,但直接因果效应证据仍无定论。
研究设计与样本
- AF-SCREEN国际协作组报告,汇总房颤与认知障碍及痴呆关联的证据并给出诊疗指导。
主要发现
- 房颤与痴呆共享众多危险因素,但关联似乎独立于这些变量。
- 提出的潜在机制包括脑微梗死、房颤相关脑低灌注、炎症、微出血、脑萎缩和系统性动脉粥样硬化性血管病。
临床怎么用
- 应依据最佳可得证据对房颤患者进行痴呆的评估与管理。
- 未来房颤研究应评估认知,并整合患者特异性结局优先级与患者偏好。
局限性
- 口服抗凝在特定亚组中的缓解作用及节律与心率控制策略的效果仍未知。
- 房颤筛查与认知障碍筛查均存在争议,需大规模前瞻性研究与随机试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Growing evidence suggests a consistent association between atrial fibrillation (AF) and cognitive impairment and dementia that is independent of clinical stroke. This report from the AF-SCREEN International Collaboration summarizes the evidence linking AF to cognitive impairment and dementia. It provides guidance on the investigation and management of dementia in patients with AF on the basis of best available evidence. The document also addresses suspected pathophysiologic mechanisms and identifies knowledge gaps for future research. Whereas AF and dementia share numerous risk factors, the association appears to be independent of these variables. Nevertheless, the evidence remains inconclusive regarding a direct causal effect. Several pathophysiologic mechanisms have been proposed, some of which are potentially amenable to early intervention, including cerebral microinfarction, AF-related cerebral hypoperfusion, inflammation, microhemorrhage, brain atrophy, and systemic atherosclerotic vascular disease. The mitigating role of oral anticoagulation in specific subgroups (eg, low stroke risk, short duration or silent AF, after successful AF ablation, or atrial cardiopathy) and the effect of rhythm versus rate control strategies remain unknown. Likewise, screening for AF (in cognitively normal or cognitively impaired patients) and screening for cognitive impairment in patients with AF are debated. The pathophysiology of dementia and therapeutic strategies to reduce cognitive impairment warrant further investigation in individuals with AF. Cognition should be evaluated in future AF studies and integrated with patient-specific outcome priorities and patient preferences. Further large-scale prospective studies and randomized trials are needed to establish whether AF is a risk factor for cognitive impairment, to investigate strategies to prevent dementia, and to determine whether screening for unknown AF followed by targeted therapy might prevent or reduce cognitive impairment and dementia.
引用
- Rivard, Friberg, Conen, et al. Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration. Circulation. 2022. PMID: 35100023. doi:10.1161/CIRCULATIONAHA.121.055018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。